Aimei Health Technology Co., Ltd Right financials
$0.0870−3.33%
Close Sep 24, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 |
| Gross margin | — | — |
| Operating income | -$835.8K | -$1.1M |
| Net income | $1.1M | $2.6M |
| Net margin | — | — |
| Diluted EPS | $0.17 | $0.28 |
| EBITDA | -$835.8K | -$1.1M |
| Operating cash flow | -$565.1K | -$672.3K |
| Free cash flow | -$565.1K | -$672.3K |
| Diluted shares | 6.2M | 9.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 |
|---|---|---|
| Cash & equivalents | $2.9K | $28.2K |
| Short-term investments | $0.00 | $0.00 |
| Total debt | $2.0M | $227.7K |
| Total assets | $12.1M | $73.8M |
| Total liabilities | $4.1M | $1.5M |
| Shareholders' equity | -$4.1M | -$1.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology